chrisvoncsefalvay/vaers-outcomes huggingface dataset:
What happened on the day April 30th is about 5 minutes after the vaccination they had me laying down already so I wouldn't pass out because I passed out on the first vaccine. I became very confused and disoriented and had brain fog that didn't go away for about 3 weeks (about the 16th of May), it lasted a really long time. I didn't know who I was or where I was and confused and on the edge of consciousness for about 45 minutes on that day. On May 13th I had a severe reaction to something and my throat closed up. Starting April 30th I had a severe cough that lasted most of May and my Doctor gave me an inhaler around the 20th of May. On May 13th I went to emergency room (they gave me Benadryl) and they couldn't find anything wrong with my heart or systems in general and kept me for observation. I then followed up with my Dr later on that week and they initially thought I had asthma and they gave me an EpiPen in case I had another reaction like that. After that I've had 5 times where I had anaphylaxis where I had to use the EpiPen and this is new because I haven't had anaphylaxis since I was 15.  Around 17th of May my brain fog started lessening and I would have 1 anaphylaxis x reaction a week since then and I continue to see my Doctor. She said I may have a genetic mast cell disorder that was activated by the vaccine. I am now on a daily emergency inhaler and EpiPen.
pt recv vax;following day,awoke w/ harsh croupy cough,sl sore throat & a runny nose;MD felt probably viral in nature; By 19feb94,sx were completely resolved;17mar94,pt recv 2nd dose w/no adverse events;
Woke up very weak. severe achiness in joints and muscles., vertigo. Went back to bed for 6 hrs. Felt a little better.
Not feeling well; This spontaneous case was reported by a patient and describes the occurrence of MALAISE (Not feeling well) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (Medical history was not provided).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form(s). On an unknown date, the patient experienced MALAISE (Not feeling well). At the time of the report, MALAISE (Not feeling well) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Patient arm was swollen and red after flu shot. There was some bleeding at time of injection. As of 8/24-patient feels better and no swelling at injection site.
itching on the left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itching on the left arm) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026C21A and 008C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PRURITUS (itching on the left arm). The patient was treated with ISOPROPANOL (RUBBING ALCOHOL) (topical) on 26-May-2021 for Itching, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (itching on the left arm) had resolved.      No concomitant medications were reported.   This case was linked to MOD-2021-177827 (Patient Link).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 25-Jul-2021: Follow-up information received contains Significant information-Updated event outcome: Recovered and lower level term for the event was updated.
Fever, chills, fatigue. A few minutes after getting up from a nap, blacked out and fell down, hitting head on kitchen shelf. Breathing but unresponsive for 10-20 seconds. Regained consciousness, but experienced severe amnesia (could not remember own age, what had happened 30 seconds ago, what had happened yesterday). EMTs responded to 911 call and transported to emergency room. Regained memory during ambulance ride.
February 17, 2021:  Patient received 1st dose of PfizerBioNTech vaccine.  Reported mild cough, nausea and bone pain lasting one week. However, she felt it wasn't severe enough to contact me as her asthma specialist.  No cough per patient for the week prior to the second dose of PfizerBioNTech. March 10, 2021:  Patient received 2nd dose of PfizerBioNTech vaccine at 1:10pm.  Said she had mild chest tightness during the waiting period and used her Ventolin but she attributed it to the characteristics of the waiting room area.  Between 5:00pm and 6:00pm (~4 hours later), she became light-headed, vomited and began to cough frequently.  She contacted her primary care physician who told her to use Mucinex and contact me if needed. March 12, 2021:  Patient contacted my office in the early afternoon.  Unable to stop coughing while on telephone.  Came to office approximately 90 minutes later.  Physical Exam;  Peak Flow 210 (personal best 310-320), oxygen saturation 93-95% (typically 97-98%), temp-98.2 F.  Intractable cough with scattered bilateral expiratory wheezes on auscultation.  Heart rate 132 and regular.  Patient treated with Levalbuterol 1.25 mg nebulization with subsequent modest improvement in frequency of cough, pulse 102, oxygen saturation 96-97%.  She declined going to emergency department of hospital because she did not want to get infected with COVID-19 from a patient in the waiting room.  She declined Prednisone when told that the corticosteroid might reduce the efficacy of the 2nd dose of the vaccine.  Placed on Budesonide 1 mg bid and Levalbuterol 1.25 mg q4-6h prn. March 16th:  Patient reported her cough was 70% improved and wanted to stop Budesonide.  Patient was told to continue Budesonide daily at 1 mg q day. April 5th:  Patient contacted my office because of continued coughing and wheezing.  Had been hospitalized March 25-27 for the cough.
This spontaneous report as received from a physician refers to a 4 month and 8 day old male patient. The patient concurrent conditions and medical history was not reported. On 16-FEB-2015 the patient was vaccinated with first dose of ROTATEQ (Dose/Frequency: 2 ml and Route: oral). No adverse effects were reported. No product quality complaint (PQC) was reported for ROTATEQ. Additional information is not expected as the reporter did not wish to contact.
Elevated pain at injection site peaking around 16 hours after injection. Generalized muscle pain (whole body), and severe headache,  beginning around 14 hours after injection and lasting more than 24 hours after injection.
Rash on my upper left thigh. Looked like a lot of little chicken scratches/Very rough to touch.; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on my upper left thigh. Looked like a lot of little chicken scratches/Very rough to touch.) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 014M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Apr-2021, the patient experienced RASH (Rash on my upper left thigh. Looked like a lot of little chicken scratches/Very rough to touch.). At the time of the report, RASH (Rash on my upper left thigh. Looked like a lot of little chicken scratches/Very rough to touch.) outcome was unknown.            No concomitant medications were reported.  No treatment medications were reported.   This case was linked to MOD-2021-032409 (Patient Link).
This spontaneous report as received from a registered nurse refers to a 45 year old female patient. No concurrent conditions, medical history or allergy/drug reactions were reported. On 12-JAN-2016 the patient was inadvertently vaccinated with ZOSTAVAX lot L034724 with expiry: 09-DEC-2016, in the right arm (dose, frequency and route not reported) instead of VARIVAX (Merck) (wrong drug administered). No adverse effects were reported. There were no product quality complaint (PQC) involved. Additional information is not expected as the reporter did not wish further contact.
sent to the emergency room for body rashes and hives.; sent to the emergency room for body rashes and hives.; This is a spontaneous report from a contactable pharmacist. This pharmacist reported similar events for 4 patients. This is the 1st of four reports. A patient with unspecified age and gender received BNT162B2 via unspecified route of administration on unspecified date at single dose for COVID-19 immunization. Medical history included allergies to bee stings. Concomitant medications were not reported. On unspecified date, the patient was sent to the emergency room for body rashes and hives, and they were recommending that those with a bee sting allergy hold off until they know more.  The outcome of events was unknown.   Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2020502533 same reporter/ drug/ events, different patient;US-PFIZER INC-2020502534 same reporter/ drug/ events, different patient;US-PFIZER INC-2020502535 same reporter/ drug/ events, different patient
COVID-19; COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 09Jan2021 at 15:00 as dose 1, single (Lot number: EN9581), in left arm, on 02Mar2021 at 10:30 as dose 2, single (Lot number: EL3261), in left arm, on 30Sep2021 at 10:00 as dose 3 (booster), single (Lot number: 301485A), in left arm and on 13Apr2022 at 13:00 as dose 4 (booster), single (Lot number: FJ4991) at the age of 68 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 27May2022 at 06:00, outcome "recovering" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results. Therapeutic measures were taken with Paxlovid as a result of drug ineffective, covid-19. Patient not have any known allergy. Patient did not received any other medication in 2 weeks. Patient taking treatment with Paxlovid from 21May2022 to 25May2022.  No follow-up attempts are possible. No further information is expected.
11.22.15 received FLUARIX PFS quad vaccine. 11.30.15 pt experienced welts/hives on back/left side (same side as Flu vaccine).
mild symptoms - like headache and sore arm; mild symptoms - like headache and sore arm; This is a spontaneous report from a contactable consumer (patient). A 44-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number was EH9899 and expiration date: not reported), dose 1 via an unspecified route of administration on 17Dec2020 as 1st dose, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. There were no any other product that were taken together with vaccine. The patient experienced mild symptoms-like headache and sore arm on an unspecified date. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
stomach nausea, Sore muscles, shoulder, back, tailbone, and joints plus, fatigue along with small headache. Had the same issue on the first vaccine that was giving on 9/24/21 with more of a pounding headache and spent the whole 3days sleeping. My fatigue felt as if I ran a marathon with no breaks. Spent most of my days sleeping until it was over.
1 week of deep fatigue (sleeping all day, no energy), slight runny nose, hoarseness
Covid-19; Covid-19; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 31-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and in Dec2021 as dose 2, single (Batch/Lot number: unknown) at the age of 31 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: VENLAFAXINE. The following information was reported: DRUG INEFFECTIVE (hospitalization, medically significant, life threatening), COVID-19 (hospitalization, medically significant, life threatening) all with onset Jan2022, outcome "not recovered" and all described as "Covid-19". The patient was hospitalized for drug ineffective, covid-19 (hospitalization duration: 1 day(s)). The event "covid-19" required emergency room visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Nasal Swab. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Drug ineffective depends on many factors including pharmacokinetics, severity of disease and patient general health condition. However on conservative basis, the possible causality cannot be excluded.
Tingling in face and heaviness feet and calves; Client took Benadryl at 15:15.  By 15:15 was better.  Spoke with client on 4/7.  Stated he was having cramps in calves and shoulder.  Other complaints resolved.  Told to go to ER if notes difficulty breathing, hives.
I've had a very loud ringing in my right ear.  No treatment thus far as there does not appear to be any.  I still have it.
Sore upper arm for over 3 weeks. Pain sometimes from shoulder down to elbow. Can't raise arm or move without intense pain. Pain has been worse after first week.
Patient received COVID vaccines on 02/06/2021 and 03/06/2021. Developed COVID symptoms; tested positive for COVID on 05/17/2021
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 39-year-old male patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment".  Additional information: Patient did not received other medication in 2 weeks. Reporters husband started taking Paxlovid on 6May and on 9May started experiencing GI upset. On 10May started with bad diarrhea for about 4 hours straight. He had to take Imodium to stop it.  The information on the batch/lot number for [BNT162B2] has been requested and will be submitted if and when received.
Tinnitus. Pressure in the head. Sensitivity to light and sound.  Going on five weeks now.
General body pain beginning at about 6 hours.  Lower body bilateral muscle cramping & pain beginning at about 10 hours, lasting 3 days, interfering with mobility. Dyspepsia at about 12 hours last 4-5 days. Continuing lower body cramping with less frequency continuing thru day 7.  Malaise and decrease in appetite day 2 thru today.
About 24 hours after TD was given pt started to run a low grade temp and had swelling of the injection site along with a hive. Mom was told to use cool comprises and benadryl and let us know if not improving. On 4/9/09 mom called office and states it was worse so at that time we had pt come in to office was seen by a FNP-BC in the office who states it was generalized erythema with firmness noted around injection site. Mom was then told to continue the Benadryl and cool comprises. and to call office if it does no improve.
I started having problems with joint inflammation.  I started with my primary care physician and he suggested physical therapy.  He also prescribed a dose pack to reduce the inflammation.  During taking the dose pack, the pain was eliminated but came back as the dosage decreased.  Physical therapy was primarily showing me how to stretch and that was not effective.  I now cannot walk to the end of my street without extreme pain in my right knee and my right hip due to inflammation.  I take over the counter Motrin to help with the pain and am not able to perform the daily tasks I normally performed that require walking more than a short distance or standing over 5 minutes.
headache; body aches; chills/Shivering; frequent urination; difficulty urinating; This case was reported by a consumer via call center representative and described the occurrence of headache in a 60-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included enlarged prostate. Concomitant products included finasteride (Proscar) and tamsulosin hydrochloride (Flomax).   On 13th November 2019, the patient received the 1st dose of Shingrix. On 13th November 2019, 2 hrs after receiving Shingrix, the patient experienced headache, general body pain, chills and urinary frequency. In November 2019, the patient experienced urination difficulty. On an unknown date, the outcome of the headache, general body pain, chills, urinary frequency and urination difficulty were unknown.   It was unknown if the reporter considered the headache, general body pain, chills, urinary frequency and urination difficulty to be related to Shingrix.  Additional details were provided as follows: The patient reported that, 2 hours aafter Shingrix vaccination, he began to experience headaches and body aches. About 8 hours later, he experienced chills and shivering and frequent urination. About 12 hours later, he experienced frequent urination and difficulty urinating and had to urinate about 6 times. The patient consented to follow up.
48 year old presents to the ER with C/O chills, sweaty and aching all over. Symptoms started the day after receiving hepatitis B vaccine. Pt had hepatitis B vaccine 2nd on 08/04/2005 and on 08/05 swelling on the left carotid area was noted. On exam three 7-10 mm raised erythematous areas were noted. Benadryl and Diphenhydramine 25 mg PRN were given.
Patient developed a reticular non-palpable, non-purpuric rash on the CONTRALATERAL arm from which she received the vaccine, about 48 hours after immunization.  Largely resolved by the next morning.
PATIENT REPORTED FEELING DIZZY AND LIGHT-HEADED WITHIN TEN MINUTES OF RECEIVING VACCINE. SHE FELT NAUSEATED  AND STATED SHE FELT LIKE SHE DID WHEN SHE HAD AN ALLERGIC REACTION TO A BEE STING THAT REQUIRED AND EPI-PEN. WE BEGAN ASSESSING THE PATIENT FOR ANAPHYLAXIS. WE GAVE DIPHENHYDRAMINE 50 MG ORALLY AND MONITORED HER HEART RATE AND BLOOD PRESSURE. HER BLOOD PRESSURE AND HEART RATE STAYED WITHIN NORMAL RANGE FOR THE NEXT 45 MINUTES. SHE REPORTED NO ANGIOEDEMA OR ANY OTHER SYMPTOMS OF ANAPHYLAXIS. WE ALSO ADMINISTERED FAMOTIDINE 20 MG TABLET. SHE CONTINUED TO DO WELL AND DID NOT EXHIBIT ANY OTHER SIGNS OF ANAPHYLAXIS. AFTER 45 MINUTES OF MONITORING THE PATIENT WITH SYMPTOMATIC QUESTIONS FOR ANAPHYLAXIS, MONITORING HER BLOOD PRESSURE AND HEART RATE, AND WITH NO OTHER SIGNS OF ANAPHYLAXIS, THE PATIENT WAS RELEASED FROM OBSERVATION. SHE REPORTED TO OUR PHARMACY ON 3/5/21 THAT SHE HAS CONTINUED TO HAVE SEVERE MUSCLE CRAMPING, SOME NAUSEA AND OVERALL FATIGUE. I COUNSELED THE PATIENT TO CONTINUE TO MAKE SURE SHE CONTINUES TO STAY WELL HYDRATED. SHE CONSULTED WITH MD AND HE ADVISED HER TO STAY HYDRATED. SHE ALSO TOOK PREDNISONE PRESCRIBED FOR A PREVIOUS KNEE INJURY, THAT THE PATIENT REPORTED.
pt recvd vax, 2 1/2 or 3 hrs broke out & itched-used cortizone help some of the itching; Next day was worse, went to md; pt told to take DPH;
Patient reports chronic pain, loss of strength, and limited movement in the arm shortly after receiving the vaccination.   He does not remember any type of injection site reaction or any systemic side effects at the time of vaccination.   Patient has had x-rays, a neurologist visit, and physical therapy due to the arm issue.  Doctors have been unable to diagnose a cause of the arm issues.   Arm issues are currently ongoing.
Patient arrived at clinic for booster dose and was provided a third dose of Pfizer. Following the dose being administered, it was identified that patient received second dose on 10/5/21 and therefore was not yet eligible for a booster. The CDC website was consulted  on this administration error and patient was counseled based on those recommendation that an additional booster would not be necessary at 6 months. Patient had no adverse signs, symptoms.
This spontaneous report was received from a 73 year old female patient regarding herself. The patient's concurrent conditions included diabetes, high blood pressure, edema and arthritis. The patient was vaccinated with ZOSTAVAX, Dose 1 injection, administered under the skin in the right arm on 01-SEP-2012. Concomitant medications included flu vaccine which was administered on 01-SEP-2012, metformin, "Glybaride", Lothartin", "Hydrochlorizide", "eye pill- vitamins for eye", "liver pill-over the counter", multivitamin, iron pills and aspirin (Bayer's aspirin 80mg daily). On 02-SEP-2012, the patient had a red hard lump that was warm and caused sore muscle type pain in and around the injection site after receiving ZOSTAVAX. The patient did not seek medical attention. The outcome of the event was unknown. Additional information is expected.